| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 检测设备及试剂(元) | 29,953,432.41 | 121,154,941.13 | 50,273,107.66 | 141,154,117.34 | 54,883,822.21 |
| 进口白蛋白(元) | - | 3,626,557,503.89 | 1,954,885,405.94 | - | 1,644,576,628.81 |
| 静丙(元) | - | 1,698,689,402.21 | 839,022,274.37 | 1,805,457,837.40 | 992,915,989.88 |
| 自产白蛋白(元) | - | 1,494,060,050.48 | 800,381,182.16 | - | 682,868,043.34 |
| 人血白蛋白(元) | - | - | - | 4,934,940,366.07 | - |
| 静注射人免疫球蛋白(元) | 721,716,268.38 | - | - | - | - |
| 其中:进口白蛋白(元) | 1,899,143,417.99 | - | - | - | - |
| 其中:自产白蛋白(元) | 678,878,983.36 | - | - | - | - |
| 其他血液制品(元) | 621,406,664.75 | 1,233,152,408.91 | 606,819,928.40 | 1,080,832,750.15 | 524,506,725.86 |
| 营业成本(元) | |||||
| 检测设备及试剂(元) | 19,572,873.43 | 78,125,197.87 | 30,007,561.55 | 102,517,282.91 | 34,374,787.42 |
| 进口白蛋白(元) | - | 3,023,870,814.68 | 1,605,828,494.05 | - | 1,317,610,780.68 |
| 静丙(元) | - | 709,654,996.77 | 346,227,501.25 | 783,075,610.57 | 431,142,486.40 |
| 自产白蛋白(元) | - | 826,320,672.11 | 430,561,271.36 | - | 378,414,234.25 |
| 人血白蛋白(元) | - | - | - | 3,651,766,312.13 | - |
| 静注射人免疫球蛋白(元) | 310,040,538.67 | - | - | - | - |
| 其中:进口白蛋白(元) | 1,582,598,046.08 | - | - | - | - |
| 其中:自产白蛋白(元) | 413,497,653.70 | - | - | - | - |
| 其他血液制品(元) | 135,050,472.61 | 218,891,542.45 | 101,251,367.14 | 177,487,323.66 | 78,932,022.82 |
| 毛利(元) | |||||
| 检测设备及试剂(元) | 10,380,558.98 | 43,029,743.26 | 20,265,546.11 | 38,636,834.43 | 20,509,034.79 |
| 进口白蛋白(元) | - | 602,686,689.21 | 349,056,911.89 | - | 326,965,848.13 |
| 静丙(元) | - | 989,034,405.44 | 492,794,773.12 | 1,022,382,226.83 | 561,773,503.48 |
| 自产白蛋白(元) | - | 667,739,378.37 | 369,819,910.80 | - | 304,453,809.09 |
| 人血白蛋白(元) | - | - | - | 1,283,174,053.94 | - |
| 静注射人免疫球蛋白(元) | 411,675,729.71 | - | - | - | - |
| 其中:进口白蛋白(元) | 316,545,371.91 | - | - | - | - |
| 其中:自产白蛋白(元) | 265,381,329.66 | - | - | - | - |
| 其他血液制品(元) | 486,356,192.14 | 1,014,260,866.46 | 505,568,561.26 | 903,345,426.49 | 445,574,703.04 |
| 毛利率(%) | |||||
| 检测设备及试剂(%) | 34.66 | 35.52 | 40.31 | 27.37 | 37.37 |
| 进口白蛋白(%) | - | 16.62 | 17.86 | - | 19.88 |
| 静丙(%) | - | 58.22 | 58.73 | 56.63 | 56.58 |
| 自产白蛋白(%) | - | 44.69 | 46.21 | - | 44.58 |
| 人血白蛋白(%) | - | - | - | 26.00 | - |
| 静注射人免疫球蛋白(%) | 57.04 | - | - | - | - |
| 其中:进口白蛋白(%) | 16.67 | - | - | - | - |
| 其中:自产白蛋白(%) | 39.09 | - | - | - | - |
| 其他血液制品(%) | 78.27 | 82.25 | 83.31 | 83.58 | 84.95 |
| 收入构成(%) | |||||
| 检测设备及试剂(%) | 0.76 | 1.48 | 1.18 | 1.77 | 1.41 |
| 进口白蛋白(%) | - | 44.37 | 45.98 | - | 42.17 |
| 静丙(%) | - | 20.78 | 19.74 | 22.67 | 25.46 |
| 自产白蛋白(%) | - | 18.28 | 18.83 | - | 17.51 |
| 人血白蛋白(%) | - | - | - | 61.98 | - |
| 静注射人免疫球蛋白(%) | 18.27 | - | - | - | - |
| 其中:进口白蛋白(%) | 48.07 | - | - | - | - |
| 其中:自产白蛋白(%) | 17.18 | - | - | - | - |
| 其他血液制品(%) | 15.73 | 15.09 | 14.27 | 13.57 | 13.45 |
| 毛利构成(%) | |||||
| 检测设备及试剂(%) | 0.70 | 1.30 | 1.17 | 1.19 | 1.24 |
| 进口白蛋白(%) | - | 18.17 | 20.09 | - | 19.71 |
| 静丙(%) | - | 29.82 | 28.36 | 31.48 | 33.86 |
| 自产白蛋白(%) | - | 20.13 | 21.28 | - | 18.35 |
| 人血白蛋白(%) | - | - | - | 39.51 | - |
| 静注射人免疫球蛋白(%) | 27.62 | - | - | - | - |
| 其中:进口白蛋白(%) | 21.24 | - | - | - | - |
| 其中:自产白蛋白(%) | 17.81 | - | - | - | - |
| 其他血液制品(%) | 32.63 | 30.58 | 29.10 | 27.82 | 26.85 |